TSH Biopharm was invited to attend the institutional investor conference hosted by Concord Securities
2023.3.7
...
TSH Board of Directors resolved to convene the 2023 Annual General Shareholders' Meeting
2023.2.24
...
TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2022
2023.2.24
...
Announcement of the Company's Acquisition of the Right-of-Use Assets From A Related Party
2022.12.22
...
TSH Board of Directors Approved Financial Statements For the Nine Months Ended September 30, 2022
2022.11.3
...
